View Item 

Show simple item record

Nifedipine in Scleroderma Ulcerations

dc.contributor.authorWoo, Thomas Y.en_US
dc.contributor.authorWong, Reynold C.en_US
dc.contributor.authorCampbell, Janis P.en_US
dc.contributor.authorGoldearb, Michael T.en_US
dc.contributor.authorVoorhees, John J.en_US
dc.contributor.authorCallen, Jeffrey P.en_US
dc.date.accessioned2010-04-01T15:03:10Z
dc.date.available2010-04-01T15:03:10Z
dc.date.issued1984-12en_US
dc.identifier.citationWoo, Thomas Y.; Wong, Reynold C.; Campbell, Janis P.; Goldearb, Michael T.; Voorhees, John J.; Callen, Jeffrey P. (1984). "Nifedipine in Scleroderma Ulcerations." International Journal of Dermatology 23(10): 678-680. <http://hdl.handle.net/2027.42/65515>en_US
dc.identifier.issn0011-9059en_US
dc.identifier.issn1365-4632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65515
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=6526563&dopt=citationen_US
dc.description.abstractCutaneous ulcerations may be due to a variety of causes, including vasculitis. infections, arterial insufficiency, and microvascular damage. The net effect is diminished blood flow to the skin. Nifedipine, a calcium antagonist, has been shown to improve cutaneous blood How and to alleviate reactive vasospastic ischemia (Raynaud's phenomenon). The authors report an ischemic ulcer of scleroderma showing visible improvement with nifedipine therapy.en_US
dc.format.extent1318290 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1984 Blackwell Science Ltden_US
dc.titleNifedipine in Scleroderma Ulcerationsen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelDermatologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Departments of Dermatology. University of Michigan Medical School, Ann Arbor. Michigan and University of Louisville School of Medicine, Louisville. Kentuckyen_US
dc.identifier.pmid6526563en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65515/1/j.1365-4362.1984.tb01233.x.pdf
dc.identifier.doi10.1111/j.1365-4362.1984.tb01233.xen_US
dc.identifier.sourceInternational Journal of Dermatologyen_US
dc.identifier.citedreferenceKahaleh MB, Osborn I, Leroy EL : Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma. Ann Intern Med 96 : 610, 1982.en_US
dc.identifier.citedreferenceCohen S, Johnson AR, Hurd E : Cytotoxicity of sera from patients with scleroderma. Arthritis Rheum 26 : 170, 1983.en_US
dc.identifier.citedreferencePeterson LL, Vorheis C : Raynaud's syndrome: Treatment with sublingual administration of nitroglycerin, swinging arm maneuver and biofeedback training. Arch Dermatol 119 : 396, 1983.en_US
dc.identifier.citedreferenceKahan A, Weber S, Amor B, et al : Nifedipine and Raynaud's phenomenon, Ann Intern Med 94 : 546, 1981.en_US
dc.identifier.citedreferenceJaffe IA : Nifedipine in digital ulceration in scleroderma. Arthritis Rheum 25 : 1267, 1982.en_US
dc.identifier.citedreferenceBraunwald E : Mechanism of action of calcium-channel blocking agents. N Engl J Med 307 : 1618, 1982.en_US
dc.identifier.citedreferenceMikkelsen E, Anderson K-E, Pedersen OL : The effect of nifedipine on isolated human peripheral vessels. Acta Pharmacol Toxicol 43 : 291, 1978.en_US
dc.identifier.citedreferenceMostbeck A, Partsch H, Peschl L : Extracardial effects of nifedipine: Measurements of liver blood flow on animals and humans and of peripheral circulation in the lower limbs : In : First International Nifedipine “Adalat” Symposium: New Therapy of Ischemic Heart Disease. Edited by Hashimoto K, Kimona E, Kobayashi T. Tokyo. University of Tokyo Press, 1970, p 303.en_US
dc.identifier.citedreferenceSchlossman K, Mederwald H, Rosenkranz H : Investigations on the metabolism and protein binding of nifedipine. Lochnerw. Second International Adalat Symposium, Berlin. Excerpta Medica 33, 1975.en_US
dc.identifier.citedreferenceAntman E, Muller J, Goldberg S, et al : Nifedipine therapy for coronary-artery spasm. N Engl J Med 302 : 1269, 1980.en_US
dc.identifier.citedreferenceKahan A, Weber S, Amor B, et al : Nifedipine for Raynaud's phenomenon. Lancet i : 131, 1983.en_US
dc.identifier.citedreferenceSmith CD, McKendry RJR : Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet ii : 1299, 1982.en_US
dc.identifier.citedreferenceRodeheffer RJ, Rommer JA, Wigley F, et al : Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon. N Engl J Med 308 : 880, 1983.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1365-4362.1984.tb01233.x.pdf
Size:
1.257MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.